Introduction:Basic information about CAS 27262-48-2|Levobupivacaine hydrochloride, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Levobupivacaine hydrochloride |
|---|
| CAS Number | 27262-48-2 | Molecular Weight | 324.889 |
|---|
| Density | / | Boiling Point | 423.4ºC at 760 mmHg |
|---|
| Molecular Formula | C18H29ClN2O | Melting Point | 254 °C (dec.)(lit.) |
|---|
| MSDS | ChineseUSA | Flash Point | 209.9ºC |
|---|
| Symbol | GHS07 | Signal Word | Warning |
|---|
Names
| Name | levobupivacaine hydrochloride (anhydrous) |
|---|
| Synonym | More Synonyms |
|---|
Levobupivacaine hydrochloride BiologicalActivity
| Description | Levobupivacaine Hcl is a local anaesthetic compound belonging to the amino amide group; long-acting local anesthetic. |
|---|
| Related Catalog | Signaling Pathways >>Autophagy >>AutophagySignaling Pathways >>Metabolic Enzyme/Protease >>PhospholipaseResearch Areas >>Others |
|---|
| References | [1]. Burlacu CL, et al. Update on local anesthetics: focus on levobupivacaine. Ther Clin Risk Manag. 2008 Apr;4(2):381-92. [2]. Gulec D, et al. Intrathecal bupivacaine or levobupivacaine: which should be used for elderly patients? J Int Med Res. 2014 Apr;42(2):376-85. |
|---|
Chemical & Physical Properties
| Boiling Point | 423.4ºC at 760 mmHg |
|---|
| Melting Point | 254 °C (dec.)(lit.) |
|---|
| Molecular Formula | C18H29ClN2O |
|---|
| Molecular Weight | 324.889 |
|---|
| Flash Point | 209.9ºC |
|---|
| Exact Mass | 324.196838 |
|---|
| PSA | 23.55000 |
|---|
| LogP | 4.74080 |
|---|
| Vapour Pressure | 2.24E-07mmHg at 25°C |
|---|
| InChIKey | SIEYLFHKZGLBNX-NTISSMGPSA-N |
|---|
| SMILES | CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- TK6120000
- CHEMICAL NAME :
- 2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride, (-)-
- CAS REGISTRY NUMBER :
- 27262-48-2
- LAST UPDATED :
- 198209
- DATA ITEMS CITED :
- 4
- MOLECULAR FORMULA :
- C18-H28-N2-O.Cl-H
- MOLECULAR WEIGHT :
- 324.94
- WISWESSER LINE NOTATION :
- T6NTJ A4 BVMR B1 F1 &GH
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 63 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 200,359,1972
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 18 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 200,359,1972
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 5100 ug/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 200,359,1972
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Parenteral
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 207 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 200,359,1972
|
Safety Information
| Symbol | GHS07 |
|---|
| Signal Word | Warning |
|---|
| Hazard Statements | H315-H319-H335 |
|---|
| Precautionary Statements | P261-P305 + P351 + P338 |
|---|
| Hazard Codes | T+: Very toxic;Xn: Harmful; |
|---|
| Risk Phrases | R20/21/22 |
|---|
| Safety Phrases | S22-S36/37/39-S45-S36/37-S53 |
|---|
| RIDADR | UN 2811 6.1/PG 2 |
|---|
| WGK Germany | 3 |
|---|
| RTECS | TK6125000 |
|---|
| HS Code | 2942000000 |
|---|
Customs
Synonyms
| levobupivacaine monohydrochloride |
| Levobupivacainehydrochloride |
| (S)-(-)-BUPIVACAINE HCL |
| Levobupivacaine Hydrochloride |
| L-BUPIVACAINE HYDROCHLORIDE |
| L-(-)-Bupivacaine |
| (S)-Bupivacaine hydrochloride |
| (RS)-bupivacaine hydrochloride |
| BUPIVACAINE HCL |
| Levobupivacaine HCl |
| bupivacaine.hydrochloride |
| MFCD01704265 |
| (-)-Bupivacaine hydrochloride |
| Chirocaine |
| (2S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride (1:1) |
| 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (2S)-, hydrochloride (1:1) |
| 1-butyl-piperidine-2-carboxylic acid-(2,6-dimethyl-anilide),hydrochloride |
| LEVAMISOLHCLSALT |
| (2S)-1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide hydrochloride (1:1) |
| (S)-(-)-Bupivacaine hydrochloride |
| (S)-Bupivacaine |
| (-)-Bupicaine Hydrochloride |
| bupicainehydrochloride(-) |
| Levobupivacaine (hydrochloride) |